{
    "clinical_study": {
        "@rank": "136404", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Evaluate the development of oral manifestations of human immunodeficiency\n      virus infection in relationship to the onset of immunologic alterations and systemic\n      symptoms in different risk groups:  gay/bisexual men, male intravenous drug users, and\n      female intravenous drug users.\n\n      II.  Evaluate the immune and inflammatory response to periodontal and other microbial\n      pathogens.\n\n      III.  Evaluate the bacterial species infecting the oral cavity in patients in these risk\n      groups."
        }, 
        "brief_title": "Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups", 
        "condition": [
            "HIV Infections", 
            "Candidiasis, Oral"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Candidiasis", 
                "Candidiasis, Oral", 
                "Oral Manifestations"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients undergo a periodontal assessment every 6 months until medically unable to continue.\n       The oral/dental exam includes saliva and gingival crevicular fluid analysis and, as\n      indicated, oral photographs."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Human immunodeficiency virus infection (HIV) seropositive or\n        seronegative At risk for HIV, i.e.: Gay/bisexual men Male intravenous drug users Female\n        intravenous drug users No acquired immunodeficiency syndrome Currently enrolled in\n        Columbia Presbyterian Medical Center protocol \"The Natural History and Progression of HIV\n        Infection\""
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "250", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004781", 
            "org_study_id": "199/11861", 
            "secondary_id": "CU-SDOS-5059"
        }, 
        "keyword": [
            "HIV-associated candidiasis", 
            "candidiasis", 
            "disease-related problem/condition", 
            "fungal infection", 
            "immunologic disorders and infectious disorders", 
            "infection", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Columbia University", 
            "last_name": "Ira B. Lamster", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004781"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Columbia University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Dental and Craniofacial Research (NIDCR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "September 1989", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "February 1997"
    }, 
    "geocoordinates": {}
}